Skip to main content
Top

Endocrine Pathology

Issue 3/2021

Content (12 Articles)

Cribriform-Morular Thyroid Carcinoma Is a Distinct Thyroid Malignancy of Uncertain Cytogenesis

Baris Boyraz, Peter M. Sadow, Sylvia L. Asa, Dora Dias-Santagata, Vania Nosé, Ozgur Mete

High Prevalence of DICER1 Mutations and Low Frequency of Gene Fusions in Pediatric Follicular-Patterned Tumors of the Thyroid

Ja-Seong Bae, Seung-Hyun Jung, Mitsuyoshi Hirokawa, Andrey Bychkov, Akira Miyauchi, Sohee Lee, Yeun-Jun Chung, Chan Kwon Jung

Open Access

Progression of Papillary Thyroid Carcinoma to Anaplastic Carcinoma in Metastatic Lymph Nodes: Solid/Insular Growth and Hobnail Cell Change in Lymph Nodes Are Predictors of Subsequent Anaplastic Transformation

Toru Odate, Naoki Oishi, Masataka Kawai, Ippei Tahara, Kunio Mochizuki, Junko Akaishi, Koichi Ito, Ryohei Katoh, Tetsuo Kondo

Follicular Epithelial Dysplasia as Hashimoto Thyroiditis-Related Atypia: a Series of 91 Specimens

Ivana Kholová, David Kalfert, Jarkko Lintusaari, Erja Rajakorpi, Marie Ludvíková

Adrenal Rests in the Uro-genital Tract of an Adult Population

Enrico Costantino Falco, Lorenzo Daniele, Jasna Metovic, Enrico Bollito, Giovanni De Rosa, Marco Volante, Mauro Papotti

Intron 4–5 hTERT DNA Hypermethylation in Merkel Cell Carcinoma: Frequency, Association with Other Clinico-pathological Features and Prognostic Relevance

Costantino Ricci, Luca Morandi, Francesca Ambrosi, Alberto Righi, Dino Gibertoni, Francesca Maletta, Claudio Agostinelli, Angelo Gianluca Corradini, Silvia Uccella, Silvia Asioli, Fausto Sessa, Stefano La Rosa, Mauro Giulio Papotti, Sofia Asioli

A Subset of Large Cell Neuroendocrine Carcinomas in the Gastroenteropancreatic Tract May Evolve from Pre-existing Well-Differentiated Neuroendocrine Tumors

Giuseppe Pelosi, Fabrizio Bianchi, Elisa Dama, Jasna Metovic, Marco Barella, Angelica Sonzogni, Adriana Albini, Mauro Papotti, Yulan Gong, Namrata Vijayvergia

PD-L1 Is Preferentially Expressed in PIT-1 Positive Pituitary Neuroendocrine Tumours

John Turchini, Loretta Sioson, Adele Clarkson, Amy Sheen, Anthony J. Gill

The Pangenomic Classification of Pituitary Neuroendocrine Tumors: Quality Histopathology is Required for Accurate Translational Research

Ozgur Mete, Shereen Ezzat, Arie Perry, Shozo Yamada, Silvia Uccella, Ashley B. Grossman, Sylvia L. Asa

Effects of CAPTEM (Capecitabine and Temozolomide) on a Corticotroph Carcinoma and an Aggressive Corticotroph Tumor

Tae Nakano-Tateno, Motoyasu Satou, Naoko Inoshita, Frank K. H. van Landeghem, Jay Easaw, Vivek Mehta, Toru Tateno, Constance L. Chik

Pendred Syndrome with C Cell Hyperplasia

Emily Bulson, Sarah Chaaban, Sylvia L. Asa

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine